debouch 发表于 2025-3-30 09:16:11

http://reply.papertrans.cn/47/4623/462298/462298_51.png

Shuttle 发表于 2025-3-30 14:11:27

http://reply.papertrans.cn/47/4623/462298/462298_52.png

祖传财产 发表于 2025-3-30 17:28:51

http://reply.papertrans.cn/47/4623/462298/462298_53.png

jungle 发表于 2025-3-30 22:56:30

http://reply.papertrans.cn/47/4623/462298/462298_54.png

negotiable 发表于 2025-3-31 03:20:09

http://reply.papertrans.cn/47/4623/462298/462298_55.png

Aggrandize 发表于 2025-3-31 06:25:32

Introduction to Lung Cancer,s a key risk factor for the disease. Small-cell carcinomas and non-small-cell carcinomas are the two types of lung cancer that may be generically categorised. Up to 75% of lung cancer cases are non-small-cell lung cancer (NSCLC), which is more prevalent. Chest radiography, sputum cytology, bronchosc

要求比…更好 发表于 2025-3-31 12:49:43

Immunobiology of Lung Cancer,rapy are likely to blame. A number of important immune cells, including as CD4+ and CD8+ T-lymphocytes, macrophages, dendritic cells, and natural killer cells, are involved in the pathogenesis of lung cancer. Growing knowledge about these cells points to a highly intricate and interconnected network

围巾 发表于 2025-3-31 15:36:00

Evolution of Lung Cancer Treatment from Classical Chemotherapy to Advanced Immunotherapy,n-small-cell lung cancer (NSCLC) is 28% and small-cell lung cancer (SCLC) is 7%. The standard care of treatment for such a deadly disease includes surgery, radiation therapy, and chemotherapy. Among these, chemotherapy is a painless treatment procedure that uses chemically formulated drugs and bioti

FADE 发表于 2025-3-31 18:01:16

http://reply.papertrans.cn/47/4623/462298/462298_59.png

积习难改 发表于 2025-3-31 22:23:24

http://reply.papertrans.cn/47/4623/462298/462298_60.png
页: 1 2 3 4 5 [6] 7
查看完整版本: Titlebook: Immunotherapy Against Lung Cancer; Emerging Opportuniti Shvetank Bhatt,Rajaraman Eri Eri,Kamal Dua Book 2024 The Editor(s) (if applicable)